Scarica l'app Stockscreener
115.43
0.16%
-0.18
Dopo l'orario di chiusura:
115.18
-0.25
-0.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$115.61
Aprire:
$115.34
Volume 24 ore:
8.78M
Relative Volume:
0.69
Capitalizzazione di mercato:
$285.39B
Reddito:
$64.93B
Utile/perdita netta:
$18.26B
Rapporto P/E:
15.87
EPS:
7.2751
Flusso di cassa netto:
$12.36B
1 W Prestazione:
-1.43%
1M Prestazione:
-4.93%
6M Prestazione:
+42.35%
1 anno Prestazione:
+22.06%
Intervallo 1D:
$114.22
$116.06
Intervallo di 1 settimana:
$114.22
$119.00
Portata 52W:
$73.31
$125.14
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
115.43 | 285.83B | 64.93B | 18.26B | 12.36B | 7.2751 |
|
LLY
Lilly Eli Co
|
989.12 | 879.67B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.19 | 582.04B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
221.45 | 388.43B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
AZN
Astrazeneca Plc
|
192.01 | 294.50B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
154.87 | 292.79B | 54.72B | 14.02B | 15.32B | 7.1855 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-02-20 | Iniziato | Barclays | Overweight |
| 2026-02-13 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Merck & Co. Inc. (NYSE:MRK) Offers a Steady Dividend Backed by Strong Fundamentals - ChartMill
Here’s Why Merck (MRK) Surged in Q4 - Insider Monkey
Merck & Co., Inc. $MRK Shares Purchased by Hamilton Wealth LLC - MarketBeat
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics - GlobeNewswire Inc.
Gotham Asset Management LLC Acquires 113,226 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fayez Sarofim & Co Has $201.96 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Focus Partners Wealth Buys 22,132 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Stock (ISIN: US58933Y1055) Hits Dividend Date as Analysts Raise Targets on Oncolog - AD HOC NEWS
Is Merck & Co., Inc. (MRK) A Good Stock To Buy Now? - Insider Monkey
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss - Insider Monkey
Elevation Point Wealth Partners LLC Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Crawford Investment Counsel Inc. Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Brevan Howard Capital Management LP Sells 355,802 Shares of Merck & Co., Inc. $MRK - MarketBeat
Circle Wealth Management LLC Has $13.62 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Cinctive Capital Management LP Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Chevy Chase Trust Holdings LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by California Public Employees Retirement System - MarketBeat
Bank of Nova Scotia Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Aquatic Capital Management LLC - MarketBeat
Aristotle Capital Management LLC Sells 317,614 Shares of Merck & Co., Inc. $MRK - MarketBeat
Ameriprise Financial Inc. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Arrow Capital Pty Ltd Invests $3.36 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Lessened by Alliancebernstein L.P. - MarketBeat
Wellington Management Group LLP Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Zuckerman Investment Group LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by M&T Bank Corp - MarketBeat
Ossiam Has $12.56 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
iSAM Funds UK Ltd Invests $4.88 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Boosted by Prudential PLC - MarketBeat
Pinnbrook Capital Management LP Purchases New Holdings in Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Comerica Bank Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Capital Wealth Planning LLC Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Glenmede Investment Management LP Has $45.31 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Benchmark Investment Advisors LLC Buys New Holdings in Merck & Co., Inc. $MRK - MarketBeat
How Merck (NYSE:MRK) Solidifies Its Financial Strength In The S&P 500 Index? - Kalkine Media
Merck & Co., Inc. Target of Unusually High Options Trading (NYSE:MRK) - MarketBeat
Tocqueville Asset Management L.P. Lowers Holdings in Merck & Co., Inc. $MRK - MarketBeat
Invesco Ltd. Grows Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Martingale Asset Management L P Sells 29,300 Shares of Merck & Co., Inc. $MRK - MarketBeat
Entropy Technologies LP Boosts Position in Merck & Co., Inc. $MRK - MarketBeat
Certuity LLC Has $2.28 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK is Arrowstreet Capital Limited Partnership's 10th Largest Position - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by American Investment Services Inc. - MarketBeat
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) - ChartMill
MRK SEC FilingsMerck & Co 10-K, 10-Q, 8-K Forms - Stock Titan
Merck (MRK) EVP Brian Foard submits initial insider Form 3 - Stock Titan
Merck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150 - 24/7 Wall St.
Wells Fargo & Company Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Wells Fargo Adjusts Price Target on Merck & Co. to $150 From $135, Maintains Overweight Rating - marketscreener.com
Douglass Winthrop Advisors LLC Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):